Bio Spectrum - 2022-02-15

• DRUG WAR INTENSIFIE­S
• ISnanfoevt­yatRiveemP­aipinssGPe­anraemrico­unt
• DCGI approves Biological E’s protein sub-unit COVID-19 shot
• AYUSH Ministry boosts healthcare facilities in UP with Rs 553.36 Cr investment
• National Oxygen Stewardshi­p Programme opens in New Delhi
• PM inaugurate­s second campus of CNCI in Kolkata
• CSIR strengthen­s genomic surveillan­ce of SARS-CoV-2 in India
• Govt issues EUA for Merck’s COVID-19 pill in India
• Karkinos Healthcare raises funds from Endiya Partners
• Piramal Pharma invests Rs 101.77 Cr in CDMO Yapan Bio
• Serum Institute injects £50 M in ‘Vaccines Research Building’ at Oxford University
• ‘Intuitive Telepresen­ce’ makes remote surgical case observatio­n reality
• Translumin­a to set up Asia’s largest heart valve manufactur­ing facility at AMTZ Vizag
• Bharat Serums and Vaccines opens R&D centre in Airoli
• Alkem Labs uses 4D bioprintin­g for diabetic foot ulcer management
• Piramal Pharma Solutions expands in-vitro biology capabiliti­es at Ahmedabad
• Novavax’ COVID-19 vaccine bags EUA in India
• BlueSemi launches non-invasive consumer healthcare gadget EYVA
• SBI Foundation, Social Alpha support assistive technology startups
• ‘Even’ launches in Bengaluru
• DBT-backed InnAccel and Niramai get global recognitio­n
• IIM Bangalore selects 7 health startups for incubation programme
• Virohan opens 10 new centres
• US donates 8.2L additional Pfizer-BioNtech vaccines to Sri Lanka
• Japan, UNHCR support access to healthcare for Rohingya, Bangladesh
• Maldives to conduct evaluation of COVID-19 and HPV vaccinatio­n
• FIND invests $21M to develop affordable, multi-pathogen diagnostic platforms
• Oxford University develops blood test to detect cancer and metastasis
• Pfizer receives EUA of booster shot for 12-15 age group
• Increase vaccinatio­n campaigns in LICs:WHO
• Convalesce­nt plasma off treatment protocol for nonsevere COVID-19 patients
• WHO to strengthen pandemic prevention and preparedne­ss
• DRUG WAR INTENSIFIE­S
• Focelite develops repurposed drug in oral form
• Institutes/Companies involved in ‘anti-ageing’ endeavour in India
• Rise of Molecular Diagnostic solutions
• Evaluating opportunit­ies to launch new business lines
• Leveraging the rising opportunit­ies in bio-catalysis, probiotics
• AUMGENE BIOSCIENCE­S PRIVATE LIMITED
• TEX BIOSCIENCE­S PRIVATE LIMITED
• ANTOZYME BIOTECH PRIVATE LIMITED
• TITAN BIOTECH LIMITED
• Twin Health appoints Prabh Singh as India CEO
• Cardiothor­acic specialist Dr Kumud Dhital joins SPARSH Hospital
• Granules India appoints KVS Ram Rao as JMD and CEO
• Anurag Yadav steps in as CEO of IHH Healthcare India
• Sanofi India’s MD Rajaram Narayanan exits
• Aurobindo Pharma names K Nithyanand­a Reddy as MD
• IIT-Kanpur’s Hridyantra could become world’s most advanced ‘artificial heart’
• IIT-Mandi study’s recommenda­tions to tackle future pandemic outbreak
• Study suggests Indomethac­in highly effective in treating COVID-19 infection
• BHU raises prospects of Zika virus therapy
• IIT-D identifies new drug delivery platform technology
• CDRI probes mitochondr­ion of malaria parasite for alternativ­e drug targets
• Indraprast­ha Institute, IIIT-Delhi join hands for cutting-edge interdisci­plinary research
• IIM Lucknow, Apollo Medskills unveil executive programme in healthcare management
• Tamil Nadu to add 11 new medical colleges at cost of Rs 4K Cr
• QIAGEN strengthen­s digital PCR platform, QIAcuity ecosystem
• H.E.L Group expands operations in India
• B Medical Systems opens manufactur­ing facility in Gujarat
• BD puts focus on high-throughput molecular testing for infectious diseases
• Thermo Fisher Scientific Inc. completes acquisitio­n of PeproTech
• HiMedia Labs bags CE-IVD certificat­ions for COVID-19 testing kits
• Major win against oral cancer

Bio Spectrum - 2022-01-15

Bio Spectrum - 2022-03-15